syncom-formulations-india-ltd
Home
Syncom Formulations (India) Ltd
SYNCOMF Share Price
BSE:
NSE:SYNCOMF
SYNCOMF Share Price
BSE:
NSE:SYNCOMF
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹2,045.44 Cr
PE Ratio
62.17
Syncom Formulations (India) Ltd Performance
▲
▲
▲
▲
Syncom Formulations (India) Ltd Fundamentals
Syncom Formulations (India) Ltd Delivery and Volume
About Syncom Formulations (India) Ltd
Incorporated as a private limited company in 1988, Syncom Formulations (India) Limited was converted into a public limited company in Jun.'92. The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Syncom possesses the manufacturing streng
| Name | Designation |
|---|---|
| Kedarmal Bankda | Chairman & Wholetime Director |
| Vijay Shankarlal Bankda | Managing Director |
| Rinki Bankda | Whole-time Director |
| Ruchi Jindal | Independent Director |
| Vaishali Agrawal | Company Sec. & Compli. Officer |
| Ritesh Kumar Lunkad | Independent Director |
| Ankit Jain | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Syncom Formulations (India) Ltd FAQs
How do I Buy Syncom Formulations (India) Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Syncom Formulations (India) Ltd shares in BlinkX.
What is the Share Price of Syncom Formulations (India) Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Syncom Formulations (India) Ltd's share price is ₹21.74 as of 2024-12-13.
What is the PE ratio of Syncom Formulations (India) Ltd?
Syncom Formulations (India) Ltd's P/E ratio is 62.17 times as of 2024-12-13.
What is the PB ratio of Syncom Formulations (India) Ltd?
Syncom Formulations (India) Ltd's most recent financial reports indicate a price-to-book ratio of 6.52, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Syncom Formulations (India) Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Syncom Formulations (India) Ltd's market capitalization is ₹2045.44 Cr as on 2024-12-13.
What is the ROE of Syncom Formulations (India) Ltd?
The current financial records of Syncom Formulations (India) Ltd show a 8.71% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Syncom Formulations (India) Ltd?
According to Syncom Formulations (India) Ltd's most recent financial filings, the company has a total asset value of ₹199.77, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Syncom Formulations (India) Ltd?
The 52-week high/low price of a Syncom Formulations (India) Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Syncom Formulations (India) Ltd's 52-week high and low as of 2024-12-13 are ₹22.6 and ₹21.6, respectively.
